Vaginal Infection Study 2

NCT ID: NCT00694928

Last Updated: 2012-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

843 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-05-31

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaginal Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

clindamycin phosphate/butoconazole nitrate

Group Type EXPERIMENTAL

clindamycin phosphate/butoconazole nitrate

Intervention Type DRUG

semi-solid, single dose

2

butoconazole nitrate

Group Type ACTIVE_COMPARATOR

butoconazole nitrate

Intervention Type DRUG

semi-solid, single dose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

clindamycin phosphate/butoconazole nitrate

semi-solid, single dose

Intervention Type DRUG

butoconazole nitrate

semi-solid, single dose

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients must have a clinical diagnosis of vaginal infection.
* Patients must be post-menopausal, surgically sterilized or using an acceptable form of birth control.

Exclusion Criteria

* Patients must not have any other infections
* May not be pregnant or nursing
* May not be receiving any other antimicrobial therapies or any medications that would interfere with the outcome of the study.
Minimum Eligible Age

16 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lumara Health, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jim Joffrion

Role: STUDY_DIRECTOR

Lumara Health, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brookwood Ob-GYN, PC/Women's Medical Plaza

Birmingham, Alabama, United States

Site Status

Drug Research Analysis Corp

Montgomery, Alabama, United States

Site Status

Drug Research and Analysis Corp.

Montgomery, Alabama, United States

Site Status

Ob/Gyn Associates

Jonesboro, Arkansas, United States

Site Status

The Woman's Clinic, PA

Little Rock, Arkansas, United States

Site Status

Peak Health Medical Group

Los Angeles, California, United States

Site Status

Women's Health Care at Frost Street

San Diego, California, United States

Site Status

Steven Freedman, MD, Inc.

West Hills, California, United States

Site Status

Red Rocks OB/GYN

Lakewood, Colorado, United States

Site Status

SHE Medical Center

Hartford, Connecticut, United States

Site Status

Debra Hemsath, MD

Largo, Florida, United States

Site Status

International Research Associates

Miami, Florida, United States

Site Status

Suncoast Clinical Research

Palm Harbor, Florida, United States

Site Status

University Clinical Research

Pines, Florida, United States

Site Status

Total Women's Health and Wellness

Decatur, Georgia, United States

Site Status

Dekalb Gynecology Associates

Decatur, Georgia, United States

Site Status

New Millennium Ob/Gyn

Riverdale, Georgia, United States

Site Status

The Woman's Clinic

Boise, Idaho, United States

Site Status

The Iowa Clinic Department of Ob/Gyn

West Des Moines, Iowa, United States

Site Status

Steven Z. Lenowitz, MD, LLC

Bel Air, Maryland, United States

Site Status

Lawrence Ob/Gyn Associates

Lawrenceville, New Jersey, United States

Site Status

Women's Health Research Center, LLC

Lawrenceville, New Jersey, United States

Site Status

Triangle Ob/Gyn

Cary, North Carolina, United States

Site Status

Women's Wellness Center

Fayetteville, North Carolina, United States

Site Status

Meridian Clinical Research, LLC

Greensboro, North Carolina, United States

Site Status

Holzer Clinic

Gallipolis, Ohio, United States

Site Status

Family Practice Center of Wadsworth, Inc

Wadsworth, Ohio, United States

Site Status

Lynn Institute of Norman

Norman, Oklahoma, United States

Site Status

Pacific Women's Center, LLC/Clinical Trials of America

Eugene, Oregon, United States

Site Status

Center for Women's Health of Lansdale

Lansdale, Pennsylvania, United States

Site Status

Creekside Women's Care

Charleston, South Carolina, United States

Site Status

The Family Healthcare Center, PA

Clinton, South Carolina, United States

Site Status

Greenville Pharmaceutical Research

Greenville, South Carolina, United States

Site Status

James T. Martin, Jr., MD, Ob/Gyn

North Charleston, South Carolina, United States

Site Status

Brown Clinical, PLLP

Watertown, South Dakota, United States

Site Status

Gynecology and Obstetrics

Memphis, Tennessee, United States

Site Status

Mid-South Ob/Gyn

Memphis, Tennessee, United States

Site Status

Kaner Medical Group, PA

Euless, Texas, United States

Site Status

Advanced Reserch Associates

McAllen, Texas, United States

Site Status

Willowbend Health & Wellness

Plano, Texas, United States

Site Status

Taylor/Wade Medical

Bountiful, Utah, United States

Site Status

Vermont Urogynecology Associates, PC

Williston, Vermont, United States

Site Status

Tidewater Clinical Research

Virginia Beach, Virginia, United States

Site Status

Bangalore Diabetes Centre

Bangalore, Karnataka, India

Site Status

AJ Medical College and Hospital

Mangalore, Karnataka, India

Site Status

Mayani Hosptial and Research Centre

Ajmer, Rajasthan, India

Site Status

Sharda Hospital

Jaipur, Rajasthan, India

Site Status

MV Hospital and Research Centre

Lucknow, Uttar Pradesh, India

Site Status

Care Hospital

Hyderabad, , India

Site Status

Shri Krishna Hospital

Jaipur, , India

Site Status

Mediciti Institute of Medical Sciences

Ranga Reddy District, , India

Site Status

Krishna Institute of Medical Sciences

Secunderabad, , India

Site Status

King George Hospital

Visakhapatnam, , India

Site Status

Kurortniy Ward City Hospital #40

Sestroretsk, Sankt-Peterburg, Russia

Site Status

Medical University Clinic

Kazan', , Russia

Site Status

Clinical Dermatovenerologic Dispensary

Krasnodar, , Russia

Site Status

State Dermatovenerology Research Center of the Federal Agency for Provision of High Technology Medical Aid

Moscow, , Russia

Site Status

State Health Care Institution Moscow City Clinical Hospital #12

Moscow, , Russia

Site Status

Russian Medical Academy of Postgraduate Studies of Roszdrav

Moscow, , Russia

Site Status

State Healthcare Institution Moscow Clinical Hospital #68

Moscow, , Russia

Site Status

Novisibirsk Municipal Dermatovenerologic Dispensary #1

Novosibirsk, , Russia

Site Status

State Health Care Institution Orenburg Regional Clinical Hospital #2

Orenburg, , Russia

Site Status

Republican Dermatovenerologic Dispensary, MoH of Karelia Republic

Petrozavodsk, , Russia

Site Status

Maximillian City Hospital #28

Saint Petersburg, , Russia

Site Status

State Healthcare Institution Regional Dermatovenerologic Dispensary

Saint Petersburg, , Russia

Site Status

S.M. Kirov Military Medical Academy, MoD of the Russian Federation

Saint Petersburg, , Russia

Site Status

City Multifield Hospital

Saint Petersburg, , Russia

Site Status

Medical Research Institute, LLC

Saint Petersburg, , Russia

Site Status

City Hospital #26

Saint Petersburg, , Russia

Site Status

St. Petersburg I.P. Pavlov State Medical University of Roszdrav

Saint Petersburg, , Russia

Site Status

Railway Clinic Hospital of the Voronezh-,1 Railway Station, RJD JSC

Voronezh, , Russia

Site Status

Voronezh Regional Clinical Dermatovenerologic Dispensary

Voronezh, , Russia

Site Status

Yaroslavl Regional Maternity Hospital

Yaroslavl, , Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States India Russia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CBC-303-603-622467

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pharmacokinetic Study of DARE-BV1
NCT05354050 COMPLETED PHASE1